Want to see IT:EUK full AI Analyst Report?
EUK Stock Chart & Stats
€0.72
-€0.02(-2.41%)
At close: 4:00 PM EST
€0.72
-€0.02(-2.41%)
Day’s Range― - ―
52-Week Range€0.45 - €0.82
Previous CloseN/A
Volume1.70K
Average Volume (3M)4.68K
Market Cap
€13.19M
Enterprise Value€142.65M
Total Cash (Recent Filing)€416.00K
Total Debt (Recent Filing)€128.29M
Price to Earnings (P/E)―
Beta0.32
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding22,741,629
10 Day Avg. Volume3,064
30 Day Avg. Volume4,678
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)0.55
Price to Sales (P/S)0.31
P/FCF Ratio36.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Stable Operating MarginsEukedos reports relatively steady operating profitability (EBIT ~9–11%, EBITDA ~20–25%) across 2021–2025. Durable operating margins indicate the core care-service business can cover operating costs and sustain service delivery, providing a structural buffer versus short-term revenue swings.
Consistent Positive Operating Cash FlowConsistently positive operating cash flow (~5–10M annually) shows the company generates cash from core service operations. Over 2–6 months this supports payroll, working capital and interest servicing, improving resilience despite episodic accounting losses and aiding near-term liquidity management.
Contract-driven Revenue ModelEukedos earns recurring fees and reimbursements under contractual arrangements for social and healthcare services. Contract-based cash flows and payer relationships tend to be structural and predictable across months, supporting revenue stability and planning for capacity, staffing and facility utilization.
Bears Say
Very High LeverageExtremely high leverage (debt/equity ~3.3–4.4x) materially limits financial flexibility and increases refinancing and interest-rate risk. Over months this raises the probability of covenant pressure or costly refinancing, constraining investment in facilities and service delivery improvements.
Return To Net LossesShifting from modest profits to net losses in 2024–2025 weakens retained earnings and capital buffers. Persistent losses reduce equity, heighten refinancing needs, and can force operational retrenchment or asset sales, undermining long-term capacity to sustain service networks and contractual commitments.
Volatile Free Cash FlowHighly volatile free cash flow—large negative in 2024 and marginally positive in 2025—means operating cash doesn't reliably cover capex and working-capital needs. This volatility impairs reinvestment in facilities, complicates debt repayment schedules, and raises long-term funding risk.
Eukedos S.p.A. News
EUK FAQ
What was Eukedos S.p.A.’s price range in the past 12 months?
Eukedos S.p.A. lowest stock price was €0.45 and its highest was €0.82 in the past 12 months.
What is Eukedos S.p.A.’s market cap?
Eukedos S.p.A.’s market cap is €13.19M.
When is Eukedos S.p.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eukedos S.p.A.’s earnings last quarter?
Currently, no data Available
Is Eukedos S.p.A. overvalued?
According to Wall Street analysts Eukedos S.p.A.’s price is currently Overvalued.
Does Eukedos S.p.A. pay dividends?
Eukedos S.p.A. pays a Notavailable dividend of €0.044 which represents an annual dividend yield of N/A. See more information on Eukedos S.p.A. dividends here
What is Eukedos S.p.A.’s EPS estimate?
Eukedos S.p.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eukedos S.p.A. have?
Eukedos S.p.A. has 22,741,629 shares outstanding.
What happened to Eukedos S.p.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eukedos S.p.A.?
Currently, no hedge funds are holding shares in IT:EUK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eukedos S.p.A.
EuKedos S.p.A. operates in Italy, offering a range of managed and long-term care provisions. The company specializes in delivering residential social support for older adults, catering to both independent individuals and those needing extensive assistance. With 1,345 beds, it oversees healthcare and residential care facilities throughout northern and central Italy, notably in regions such as Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is headquartered in Florence, Italy.
Technical Analysis
Arterra Bioscience SpA
―
Farmacosmo S.P.A.
―
Svas Biosana S.p.A.
―
I.M.D. International Medical Devices S.P.A.
―
Piu Medical S.P.A.
―